U.S. Markets close in 18 mins

How Did Gilead’s Blockbuster Drug Harvoni Perform in 2Q17?

Mike Benson

Harvoni is the top-selling drug in Gilead Sciences’ (GILD) portfolio. The drug is used for the treatment of genotype-1 hepatitis C virus (or HCV) infection.